GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (LTS:0RK9) » Definitions » EV-to-FCF

Alligator Bioscience AB (LTS:0RK9) EV-to-FCF : -0.51 (As of Mar. 27, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Alligator Bioscience AB EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Alligator Bioscience AB's Enterprise Value is kr107.74 Mil. Alligator Bioscience AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was kr-212.43 Mil. Therefore, Alligator Bioscience AB's EV-to-FCF for today is -0.51.

The historical rank and industry rank for Alligator Bioscience AB's EV-to-FCF or its related term are showing as below:

LTS:0RK9' s EV-to-FCF Range Over the Past 10 Years
Min: -39.12   Med: -2.73   Max: 0.45
Current: -0.51

During the past 11 years, the highest EV-to-FCF of Alligator Bioscience AB was 0.45. The lowest was -39.12. And the median was -2.73.

LTS:0RK9's EV-to-FCF is ranked worse than
100% of 428 companies
in the Biotechnology industry
Industry Median: 2.855 vs LTS:0RK9: -0.51

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-27), Alligator Bioscience AB's stock price is kr0.0077. Alligator Bioscience AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was kr-0.028. Therefore, Alligator Bioscience AB's PE Ratio (TTM) for today is At Loss.


Alligator Bioscience AB EV-to-FCF Historical Data

The historical data trend for Alligator Bioscience AB's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alligator Bioscience AB EV-to-FCF Chart

Alligator Bioscience AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.37 -2.35 -1.56 -2.10 -0.79

Alligator Bioscience AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.10 -2.79 -3.80 -4.09 -0.79

Competitive Comparison of Alligator Bioscience AB's EV-to-FCF

For the Biotechnology subindustry, Alligator Bioscience AB's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alligator Bioscience AB's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alligator Bioscience AB's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Alligator Bioscience AB's EV-to-FCF falls into.


';

Alligator Bioscience AB EV-to-FCF Calculation

Alligator Bioscience AB's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=107.744/-212.425
=-0.51

Alligator Bioscience AB's current Enterprise Value is kr107.74 Mil.
Alligator Bioscience AB's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-212.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alligator Bioscience AB  (LTS:0RK9) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Alligator Bioscience AB's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0077/-0.028
=At Loss

Alligator Bioscience AB's share price for today is kr0.0077.
Alligator Bioscience AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.028.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Alligator Bioscience AB EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Alligator Bioscience AB's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Alligator Bioscience AB Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.

Alligator Bioscience AB Headlines

No Headlines